264: Messy PBM conflicts, debatable vaccines, & the future of flu season
The Readout Loud
00:00
The Committee's Concerns About RSV Vaccines
There's a lot of competition right now to get out into the marketplace with RSV. G&J has already announced that it was shelving its RSV efforts. And you know, there's not such a huge incentive to bring a third or fourth vaccine to market.
Transcript
Play full episode
